Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ultragenyx Pharmaceutical Inc (RARE)  
$41.40 0.37 (0.89%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,110,000
Market Cap: 3.40(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.73 - $53.69
Level I Sector: Consumer Discretionary
Level II Sector: Leisure
Level III Sector: Restaurants

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    NASDAQ INDUSTRIAL     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,005 99,487 197,241 249,694
Total Sell Value $596,362 $4,824,734 $8,130,065 $10,494,293
Total People Sold 2 8 9 12
Total Sell Transactions 3 12 19 35
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 628
  Page 23 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Huizenga Theodore Alan Controller and PAO   •       –      –    2015-12-18 4 S $110.55 $165,825 D/D (1,500) 2,500     -
   Huizenga Theodore Alan Controller and PAO   •       –      –    2015-12-18 4 OE $21.00 $31,500 D/D 1,500 4,000     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2015-12-10 4 AS $101.03 $1,219,957 D/D (12,000) 41,801     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2015-12-10 4 OE $0.82 $9,780 D/D 12,000 53,801     -
   Kakkis Emil D President & CEO   •       •      –    2015-11-30 4 AS $96.46 $1,965,427 D/D (20,000) 595,640     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-11-23 4 AS $95.88 $47,748 D/D (498) 13,775     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-11-19 4 D $97.71 $53,154 D/D (544) 14,273     -
   Kakkis Emil D President & CEO   •       •      –    2015-10-30 4 AS $98.63 $1,991,407 D/D (20,000) 615,640     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-10-20 4 AS $85.51 $55,496 D/D (649) 14,817     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-10-19 4 D $88.94 $34,864 D/D (392) 15,466     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-09-22 4 AS $109.51 $54,536 D/D (498) 15,858     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-09-19 4 D $129.91 $70,671 D/D (544) 16,356     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-08-20 4 AS $107.30 $1,892,212 D/D (17,020) 16,900     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-08-20 4 OE $55.88 $558,800 D/D 10,000 26,900     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2015-08-19 4 D $116.99 $641,105 D/D (5,480) 23,920     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2015-08-12 4 AS $109.70 $365,740 D/D (3,334) 70,204     -
   Dallas Jayson Donald Alexander See Remarks   •       –      –    2015-08-04 4 A $0.00 $0 D/D 10,000 10,000     -
   Aliski William Director   –       •      –    2015-07-27 4 AS $122.58 $49,032 I/I (400) 109,000     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2015-07-20 4 AS $130.99 $508,532 D/D (3,854) 41,801     -
   Pinion John Richard See Remarks   •       –      –    2015-07-16 4 A $0.00 $0 D/D 7,500 7,500     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2015-07-08 4 AS $102.12 $340,468 D/D (3,334) 73,538     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2015-06-18 4 AS $95.95 $384,340 D/D (4,000) 45,655     -
   Huizenga Theodore Alan Controller and PAO   •       –      –    2015-06-17 4/A S $94.80 $142,200 D/D (1,500) 4,300     -
   Huizenga Theodore Alan Controller and PAO   •       –      –    2015-06-17 4/A OE $21.00 $31,500 D/D 1,500 5,800     -
   Huizenga Theodore Alan Controller and PAO   •       –      –    2015-06-17 4 S $94.80 $142,200 D/D (1,500) 2,500     -
  628 Records found
  Previous  20  21  22  23  24  25  26   
  Page 23 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us